Product Overview

Glycomet 500 mg is a prescription oral medication formulated to help adults manage type 2 diabetes mellitus. Manufactured by USV Pvt Ltd, each strip contains ten tablets delivering a consistent 500 milligram dose of the active ingredient Metformin. The product is packaged for convenience and is intended for patients who require reliable glycemic control as part of a comprehensive diabetes care plan. This medication is available in multiple pack sizes, including 100, 200, and 300 tablets, allowing flexible ordering for long‑term therapy. Shipping typically takes between six and fifteen days, depending on the destination. For a comprehensive overview of diabetes management, visit the National Institutes of Health diabetes page.

What is Glycomet 500 mg (Metformin)

Glycomet 500 mg contains the oral antidiabetic agent Metformin, a member of the biguanide class of drugs. The active ingredient works systemically to lower blood glucose without stimulating insulin secretion, making it distinct from sulfonylureas. Metformin is the only oral hypoglycemic that has demonstrated cardiovascular benefit in large outcome trials. The 500 milligram strength is often used as a starting dose because it provides an effective glycemic reduction while minimizing gastrointestinal discomfort. The product is marketed under the brand name Glycomet and is supplied by USV Pvt Ltd, a manufacturer with a longstanding presence in the Indian pharmaceutical market.

Uses and Benefits

The primary use of Glycomet 500 mg is the management of type 2 diabetes mellitus in adults who have not achieved adequate control through diet and exercise alone. When incorporated into a comprehensive treatment plan, it helps reduce fasting plasma glucose and post‑prandial glucose excursions, thereby lowering the risk of long‑term complications such as neuropathy, retinopathy, and nephropathy. Clinical studies have shown that consistent use of Metformin can improve HbA1c levels by approximately one to one and a half percent. In addition to glucose control, Metformin has been associated with modest weight stabilization and a favorable impact on lipid profiles, including reductions in triglycerides and low‑density lipoprotein cholesterol. These attributes make Glycomet a cornerstone therapy for many patients seeking durable metabolic control.

How It Works

Metformin exerts its antihyperglycemic effect through several interconnected mechanisms. First, it suppresses hepatic gluconeogenesis, reducing the liver’s production of glucose. Second, it enhances peripheral insulin sensitivity, allowing muscle and adipose tissue to uptake glucose more efficiently. Third, it increases the activity of AMP‑activated protein kinase (AMPK), a cellular energy sensor that modulates metabolic pathways. The net result is a decrease in blood glucose concentration without causing hypoglycemia when used as monotherapy. For a deeper scientific review, see the PubMed Central entry on Metformin mechanisms.

Dosage Guidelines

Dosage of Glycomet 500 mg is individualized based on patient response, renal function, and concomitant therapies. The usual starting regimen is one tablet taken once daily with the evening meal to reduce gastrointestinal upset. After several weeks, the dose may be increased by 500 mg at weekly intervals, aiming for a total daily dose of 1000 to 2000 mg, divided into two doses if higher amounts are required. Tablets should be swallowed whole with adequate water and should not be crushed or chewed. Patients with estimated glomerular filtration rate (eGFR) above 60 mL/min/1.73 m² may continue at the full dose, while those with eGFR between 30 and 60 mL/min/1.73 m² often require dose reduction. Regular monitoring of renal function is essential, and the medication should be temporarily discontinued prior to radiographic contrast procedures. Always follow the guidance of your prescribing clinician when adjusting the dose. More information is available at the MedlinePlus drug page.

Side Effects

Like all medications, Glycomet 500 mg can produce side effects, most of which are mild and transient. The most frequently reported adverse reactions include nausea, vomiting, diarrhea, abdominal discomfort, and a metallic taste. These symptoms typically improve after the first few weeks as the gut adapts to the drug. In rare cases, Metformin can lead to vitamin B12 deficiency, especially with long‑term use, so periodic supplementation may be advisable. Although extremely uncommon, a serious condition known as lactic acidosis can occur, particularly in patients with impaired renal function, severe hypoxia, or those who consume alcohol excessively. Signs of lactic acidosis include rapid breathing, muscle weakness, and unexplained fatigue, and require immediate medical attention. For detailed safety data, see the Drugs.com Metformin page.

Warnings and Precautions

Warnings and precautions associated with Glycomet 500 mg emphasize the importance of renal assessment before initiation. The drug is contraindicated in patients with an eGFR below 30 mL/min/1.73 m² or in those with a history of lactic acidosis. Caution is also advised in individuals with hepatic impairment, heart failure, or conditions that predispose to hypoxia such as chronic obstructive pulmonary disease. Pregnant or breastfeeding women should consult their physician, as the safety of Metformin in these populations remains under investigation. Additionally, patients scheduled for surgical procedures or diagnostic imaging involving contrast dye should inform their healthcare provider, as temporary discontinuation may be recommended to reduce the risk of complications. For the official prescribing information, refer to the FDA label.

Frequently Asked Questions

• Q: How should I store Glycomet 500 mg tablets? A: Keep the strips at room temperature, away from moisture and direct sunlight.
• Q: Can Glycomet be used in patients with kidney disease? A: It is not recommended for severe renal impairment; consult a healthcare professional for dose adjustment.
• Q: Is lactic acidosis a common side effect? A: Lactic acidosis is rare but serious; seek immediate medical attention if you experience unusual muscle pain or dizziness.
• Q: Does Metformin cause weight loss? A: It is weight‑neutral or may cause modest weight loss in some patients.
• Q: Can I take Glycomet with other diabetes medications? A: Combination therapy is possible but must be managed by a physician to avoid hypoglycemia.

Related Products

• Erytop Gel (Clindamycin)
• Okamet 500 Mg (Metformin)
• Angispan TR (Nitroglycerin/Glyceryl Trinitrate)
• Angispan TR 2.5 mg (Nitroglycerin/Glyceryl Trinitrate)
• Angispan TR 6.5 mg (Nitroglycerin/Glyceryl Trinitrate)
• Glimepiride 2 mg (Generic)
• Glimepiride 1 mg (Generic)
• Glycomet-GP 0.5 Forte (Metformin/Glimepiride)
• Glycomet-GP 0.5 Tablet (Metformin/Glimepiride)
• Forxiga 5mg (Dapagliflozin)
• Glycomet-GP 1 Tablet (Metformin/Glimepiride)
• Amaryl M 1mg (Metformin/Glimepiride)